Home Cart 0 Sign in  
X

[ CAS No. 110301-23-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 110301-23-0
Chemical Structure| 110301-23-0
Chemical Structure| 110301-23-0
Structure of 110301-23-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 110301-23-0 ]

Related Doc. of [ 110301-23-0 ]

Alternatived Products of [ 110301-23-0 ]

Product Details of [ 110301-23-0 ]

CAS No. :110301-23-0 MDL No. :MFCD03407467
Formula : C7H4F2N2 Boiling Point : -
Linear Structure Formula :- InChI Key :KVHGANXAAWNSFM-UHFFFAOYSA-N
M.W : 154.12 Pubchem ID :280467
Synonyms :

Calculated chemistry of [ 110301-23-0 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 35.48
TPSA : 49.81 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.42 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.31
Log Po/w (XLOGP3) : 1.16
Log Po/w (WLOGP) : 2.27
Log Po/w (MLOGP) : 1.66
Log Po/w (SILICOS-IT) : 1.93
Consensus Log Po/w : 1.66

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.93
Solubility : 1.81 mg/ml ; 0.0118 mol/l
Class : Very soluble
Log S (Ali) : -1.8
Solubility : 2.44 mg/ml ; 0.0158 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.67
Solubility : 0.332 mg/ml ; 0.00215 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.52

Safety of [ 110301-23-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 110301-23-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 110301-23-0 ]
  • Downstream synthetic route of [ 110301-23-0 ]

[ 110301-23-0 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 110301-23-0 ]
  • [ 123688-59-5 ]
YieldReaction ConditionsOperation in experiment
54%
Stage #1: at 20℃; for 1 h;
Stage #2: With hydrogen bromide; copper(I) bromide In water at 20℃; for 13.5 h;
To concentrated sulfuric acid (25 mL) was added sodium nitrite (3.20 g) portionwise at 5 °C, and the mixture was stirred at room temperature for 0.5 h. The mixture was cooled down to 5 °C, and then acetic acid (40 mL) was added dropwise to the mixture. The mixture was stirred at 5 °C for 5 min. To the mixture was added 4-amino-3,5-difluorobenzonitrile (8, 6.50 g) portionwise, and then the mixture was stirred at room temperature for 1 h. The mixture was transferred into a dropping funnel, and was added dropwise to a solution of copper(I) bromide (9.07 g) in 47 wt percent hydrobromic acid (25 mL) over 0.5 h. The mixture was stirred at room temperature for 13 h. Water (300 mL) was added to the mixture, and the mixture was extracted with ethyl acetate. The organic layer was washed with brine, and then dried. The desiccant was removed by filtration and the filtrate was evaporated in vacuo. The resulting residue was purified by silica gel column chromatography (hexane-ethyl acetate) to obtain 9g (5.00 g, 54percent) as a white solid: 1H NMR (DMSO-d6) δ 7.98 (2H, d, J = 6.3 Hz); EI-MS m/z 217, 219 [(M)+].
Reference: [1] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 17, p. 5235 - 5246
[2] Patent: WO2018/75871, 2018, A1, . Location in patent: Page/Page column 68
  • 2
  • [ 110301-23-0 ]
  • [ 123688-59-5 ]
Reference: [1] Patent: US5354502, 1994, A,
  • 3
  • [ 110301-23-0 ]
  • [ 7787-70-4 ]
  • [ 123688-59-5 ]
Reference: [1] Patent: US5200110, 1993, A,
[2] Patent: US5030382, 1991, A,
[3] Patent: US4883609, 1989, A,
  • 4
  • [ 67567-26-4 ]
  • [ 110301-23-0 ]
YieldReaction ConditionsOperation in experiment
86% for 1.5 h; Reflux A mixture suspension of 4-bromo-2,6-difluoroaniline (7, 25.85 g) and copper(I) cyanide (16.70 g) in NMP (60 mL) was stirred at reflux temperature for 1.5 h and then cooled down to room temperature. To the mixture was added 1,2-diaminoethane (23 mL) and the mixture was poured into water (150 mL). The mixture was extracted with ethyl acetate and the organic layer was washed with 10 wt percent 1,2-diaminoethane solution in water and water, and then dried. The desiccant was removed by filtration and the filtrate was evaporated in vacuo. The resulting residue was purified by silica gel column chromatography (hexane-ethyl acetate) to obtain 8 (16.54 g, 86percent) as a pale yellow solid: 1H NMR (DMSO-d6) δ 6.36 (2H, s), 7.50 (2H, dd, J = 2.7, 6.7 Hz); EI-MS m/z 154 [(M)+].
Reference: [1] Journal of Materials Chemistry C, 2016, vol. 4, # 23, p. 5326 - 5333
[2] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 17, p. 5235 - 5246
[3] Journal of the American Chemical Society, 2012, vol. 134, # 51, p. 20597 - 20600
[4] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 3, p. 250 - 255
[5] Patent: WO2018/136935, 2018, A1, . Location in patent: Paragraph 00407
  • 5
  • [ 141743-49-9 ]
  • [ 544-92-3 ]
  • [ 110301-23-0 ]
YieldReaction ConditionsOperation in experiment
66% for 2 h; Heating / reflux A mixture of the solid and CuCN in DMF was heated with reflux for 2 days and then filtered through celite. The filtrate was dissolved in methylene chloride and water, and the aqueous phase was extracted with methylene chloride. The combined organic layer was washed with brine, dried over anhyd. MgSO4, filtered, and concentrated under reduced pressure. The crude residue was column-chromatographed (hexane/ethylacetate = 4/1) to yield a yellow solid (1.03g, 66percent).1HNMR (300MHz, CDC13): 7.15 (dd, 2H, J= 2.4 and 6.0 Hz), 4.28 (bs, 2H).
Reference: [1] Patent: WO2006/98554, 2006, A1, . Location in patent: Page/Page column 78
  • 6
  • [ 67567-26-4 ]
  • [ 110301-23-0 ]
Reference: [1] Patent: US5354502, 1994, A,
  • 7
  • [ 67567-26-4 ]
  • [ 110301-23-0 ]
Reference: [1] Patent: US5030382, 1991, A,
  • 8
  • [ 67567-26-4 ]
  • [ 110301-23-0 ]
Reference: [1] Bioconjugate Chemistry, 2018, vol. 29, # 2, p. 324 - 334
  • 9
  • [ 110301-23-0 ]
  • [ 500577-99-1 ]
YieldReaction ConditionsOperation in experiment
84% at 110℃; for 16 h; 4-amino-3,5-difluorobenzonitrile (354.3 mg, 2.3 mmol) was suspended in 1M aqueous sodium hydroxide (12 mL) and the resulting suspension was heated at 110 °C for 16 h. After cooling, the mixture was washed with ether. The aqueous phase was acidified to pH = 2 with 10percent KHS04/Na2S04 buffer and extracted with EtOAc (2X). The combined EtOAc extracts were washed with water, and then brine, dried over anhydrous sodium sulfate and concentrated in vacuo to provide 4-amino-3,5-difluorobenzoic acid (335 mg, 84percent yield) as a yellow solid. 1H NMR (300 MHz, Chloroform-d) δ 7.66 - 7.58 (m, 2H).
Reference: [1] Journal of Materials Chemistry C, 2016, vol. 4, # 23, p. 5326 - 5333
[2] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 3, p. 250 - 255
[3] Patent: WO2018/136935, 2018, A1, . Location in patent: Paragraph 00408
[4] Bioconjugate Chemistry, 2018, vol. 29, # 2, p. 324 - 334
[5] Journal of the American Chemical Society, 2012, vol. 134, # 51, p. 20597 - 20600
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 110301-23-0 ]

Fluorinated Building Blocks

Chemical Structure| 859855-53-1

[ 859855-53-1 ]

3-Amino-4-fluorobenzonitrile

Similarity: 0.91

Chemical Structure| 63069-50-1

[ 63069-50-1 ]

4-Amino-3-fluorobenzonitrile

Similarity: 0.91

Chemical Structure| 115661-37-5

[ 115661-37-5 ]

2-Amino-3-fluorobenzonitrile

Similarity: 0.88

Chemical Structure| 210992-28-2

[ 210992-28-2 ]

3-Amino-5-fluorobenzonitrile

Similarity: 0.84

Chemical Structure| 53312-81-5

[ 53312-81-5 ]

5-Amino-2-fluorobenzonitrile

Similarity: 0.82

Aryls

Chemical Structure| 859855-53-1

[ 859855-53-1 ]

3-Amino-4-fluorobenzonitrile

Similarity: 0.91

Chemical Structure| 63069-50-1

[ 63069-50-1 ]

4-Amino-3-fluorobenzonitrile

Similarity: 0.91

Chemical Structure| 115661-37-5

[ 115661-37-5 ]

2-Amino-3-fluorobenzonitrile

Similarity: 0.88

Chemical Structure| 210992-28-2

[ 210992-28-2 ]

3-Amino-5-fluorobenzonitrile

Similarity: 0.84

Chemical Structure| 53312-81-5

[ 53312-81-5 ]

5-Amino-2-fluorobenzonitrile

Similarity: 0.82

Amines

Chemical Structure| 859855-53-1

[ 859855-53-1 ]

3-Amino-4-fluorobenzonitrile

Similarity: 0.91

Chemical Structure| 63069-50-1

[ 63069-50-1 ]

4-Amino-3-fluorobenzonitrile

Similarity: 0.91

Chemical Structure| 115661-37-5

[ 115661-37-5 ]

2-Amino-3-fluorobenzonitrile

Similarity: 0.88

Chemical Structure| 210992-28-2

[ 210992-28-2 ]

3-Amino-5-fluorobenzonitrile

Similarity: 0.84

Chemical Structure| 53312-81-5

[ 53312-81-5 ]

5-Amino-2-fluorobenzonitrile

Similarity: 0.82

Nitriles

Chemical Structure| 859855-53-1

[ 859855-53-1 ]

3-Amino-4-fluorobenzonitrile

Similarity: 0.91

Chemical Structure| 63069-50-1

[ 63069-50-1 ]

4-Amino-3-fluorobenzonitrile

Similarity: 0.91

Chemical Structure| 115661-37-5

[ 115661-37-5 ]

2-Amino-3-fluorobenzonitrile

Similarity: 0.88

Chemical Structure| 210992-28-2

[ 210992-28-2 ]

3-Amino-5-fluorobenzonitrile

Similarity: 0.84

Chemical Structure| 53312-81-5

[ 53312-81-5 ]

5-Amino-2-fluorobenzonitrile

Similarity: 0.82